Back to Awarded Treatment Trials
Awarded Trial: 03T-342
Grant ID
03T-342
Illness
Schizophrenia
Primary Drug/Intervention
Pergolide
Primary Dosage
0.3mg/d
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Roesch - Ely
Sample Size
60
Duration of Study Period for Each Subject
30 days
Outcome Measurements
Cognitive battery, PANSS
Results
Twenty-one patients completed the study. There was no significant difference between drug and placebo on PANSS ratings. Patients randomized to receive pergolide exhibited a significant, but subtle, improvement in auditory working memory.
Publication
N/A
Link
N/A
PI Name
Daniela Roesch - Ely
Degree
MD
Center
University of Heidelberg
Institution
Psychiatrische Universitaetsklinik Heidelberg
Address
Vosstrasse 2
City or Town
Heidelberg
State or Province
N/A
Zip or Postal Code
69115
Country
Germany
Email Address
Daniela.Roesch@med.uni-heidelberg.de